Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Luis F. Angel

November 01, 2017

News Conference News TCT 2017

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Shelley Wood

November 01, 2017

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

Devices - Needles, Wires and Sheaths

Presenter: Paul Sorajja

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Clinical Trials Using RAPID: Some POC Thoughts

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Theodore Heise

October 30, 2017

Presentation TCT 2017

RAPID Program: Industry View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Robert Thatcher

October 30, 2017

Presentation TCT 2017

RAPID Program: Academic View

Presenter: Schuyler Jones, Hiroyoshi Yokoi

October 30, 2017

Advertisement

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Early Pilot Study Results Show Symptom Improvement With TMVR

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Devices - Needles, Wires and Sheaths

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Long-term Absorb BVS Data Continue to Disappoint

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Clinical Trials Using RAPID: Some POC Thoughts

RAPID Program: Industry View

RAPID Program: Academic View

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content